Efavirenz, Emtricitabine, And Tenofovir Disoproxil Fumarate
NDC Package 64380-739-04

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Efavirenz, Emtricitabine, And Tenofovir Disoproxil Fumarate is a . Marketed by Strides Pharma Science Limited, this product is identified by NDC 64380-739 and is authorized under FDA application ANDA201802.

Identification & Billing

NDC Package Code
64380-739-04
Package Description
1 BOTTLE in 1 BOTTLE / 30 TABLET in 1 BOTTLE
Product Code
64380-739
11-Digit Billing Format
64380073904

Clinical Specifications

Proprietary Name
Efavirenz, Emtricitabine, And Tenofovir Disoproxil Fumarate
Dosage Form
-

Regulatory & Marketing

Labeler Name
Strides Pharma Science Limited
FDA Application #
ANDA201802
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
10-11-2025
End Marketing Date
10-12-2025
Listing Expiration
10-12-2025
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 64380-739-04 identifies a specific commercial package of 1 bottle in 1 bottle / 30 tablet in 1 bottle of Efavirenz, Emtricitabine, And Tenofovir Disoproxil Fumarate, labeled by Strides Pharma Science Limited. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Strides Pharma Science Limited on October 11, 2025. The current certification is valid through October 12, 2025.

How is this Strides Pharma Science Limited product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 64380073904. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
64380-739-04
11-Digit CMS (5-4-2)
64380-0739-04

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.